Sorafenib in Newly Diagnosed High Grade Glioma

This study has been completed.
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Andreas F. Hottinger, University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT00884416
First received: April 17, 2009
Last updated: October 31, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Publications: